Wave Life Sciences Ltd Sustainability Reports
Wave Life Sciences Ltd. is a clinical-stage biotechnology company focused on developing stereopure RNA medicines. The company leverages its proprietary PRISM platform to target rare and common genetic disorders.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 54930070006GPKFYZ813
FIGI: BBG00B642V63
4 reports from 2015 to 2023